SCHEMBL28065141

SCHEMBL28065141

CC(C(=O)O)c1ccc(NS(=O)(=O)C(C)C)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 5/20 0.49
NR1H4 Q96RI1 1/20 0.47
LMNA P02545 5/20 0.46
PTGS1 P23219 4/20 0.46
AKR1C3 P42330 4/20 0.46
AKR1C2 P52895 3/20 0.46
ADRB3 P13945 3/20 0.46
CYP2C9 P11712 2/20 0.46
CXCR1 P25024 2/20 0.46
CXCR2 P25025 2/20 0.46
BLM P54132 2/20 0.46
ALB P02768 1/20 0.46
ESR1 P03372 1/20 0.46
ALOX5 P09917 1/20 0.46
RARB P10826 1/20 0.46
NFKB1 P19838 1/20 0.46
HTR2A P28223 1/20 0.46
NR1I3 Q14994 1/20 0.46
SLC22A6 Q4U2R8 1/20 0.46
CXCL8 P10145 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12129521 1.00 PTGS2 (0.49) PTGS2NR1H4LMNAPTGS1AKR1C3
SCHEMBL966466 0.85 LMNA (0.41) LMNAADRB3CXCR1CXCR2BLM
SCHEMBL966639 0.85 EPHX1 (0.47) LMNAADRB3BLMADRB2ADRB1
SCHEMBL25167208 0.85 EPHX1 (0.47) LMNAADRB3BLMADRB2ADRB1
SCHEMBL16322044 0.85 LMNA (0.41) LMNAADRB3CXCR1CXCR2BLM
SCHEMBL15456905 0.84 LMNA (0.56) PTGS2NR1H4LMNAPTGS1AKR1C3
SCHEMBL27602626 0.84 PTGS2 (0.50) PTGS2NR1H4LMNAPTGS1AKR1C3
SCHEMBL1345262 0.84 LMNA (0.56) PTGS2NR1H4LMNAPTGS1AKR1C3
SCHEMBL1345370 0.84 LMNA (0.56) PTGS2NR1H4LMNAPTGS1AKR1C3
SCHEMBL27602625 0.84 PTGS2 (0.50) PTGS2NR1H4LMNAPTGS1AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105722972-A Cellular factors involved in the cytotoxicity of leukocidins of staphylococcus aureus: novel therapeutic target 纽约大学 2016-06-29 CN disclosed